Article ID Journal Published Year Pages File Type
4322047 Neuron 2011 14 Pages PDF
Abstract

SummaryHuntington's disease-like-2 (HDL2) is a phenocopy of Huntington's disease caused by CTG/CAG repeat expansion at the Junctophilin-3 (JPH3) locus. The mechanisms underlying HDL2 pathogenesis remain unclear. Here we developed a BAC transgenic mouse model of HDL2 (BAC-HDL2) that exhibits progressive motor deficits, selective neurodegenerative pathology, and ubiquitin-positive nuclear inclusions (NIs). Molecular analyses reveal a promoter at the transgene locus driving the expression of a CAG repeat transcript (HDL2-CAG) from the strand antisense to JPH3, which encodes an expanded polyglutamine (polyQ) protein. Importantly, BAC-HDL2 mice, but not control BAC mice, accumulate polyQ-containing NIs in a pattern strikingly similar to those in the patients. Furthermore, BAC mice with genetic silencing of the expanded CUG transcript still express HDL2-CAG transcript and manifest polyQ pathogenesis. Finally, studies of HDL2 mice and patients revealed CBP sequestration into NIs and evidence for interference of CBP-mediated transcriptional activation. These results suggest overlapping polyQ-mediated pathogenic mechanisms in HD and HDL2.

► An expanded CAG transcript mediates polyglutamine toxicity in HDL2 mice ► HDL2 mice with genetic silencing of CUG transcripts still manifest polyQ toxicity ► HDL2 and HD may share overlapping mechanisms in polyQ-mediated CBP interference

Related Topics
Life Sciences Neuroscience Cellular and Molecular Neuroscience
Authors
, , , , , , , , , , , , , , ,